AmacaThera

AmacaThera

Signal active

Organization

Contact Information

Overview

AmacaThera is a clinical-stage biotechnology company developing a novel drug delivery platform to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer, and other hard‑to‑reach target areas. AmacaThera is developing combination products at the interface of biomaterials and pharmaceuticals.

About

Industries

Biotechnology, Biopharma, Therapeutics

Founded

2016

Employees

1-10

Headquarters locations

Toronto, Ontario, Canada, North America

Social

Profile Resume

AmacaThera headquartered in North America, operates in the Biotechnology, Biopharma, Therapeutics sector. The company focuses on Biotechnology and has secured $1.3B in funding across 84 round(s). With a team of 1-10 employees, AmacaThera is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - AmacaThera, raised $50.0K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Molly Shoichet

Molly Shoichet

Co-Founder and Chief Science Officer at AmacaThera.

imagePlace Mike Cooke

Mike Cooke

Co-Founder and Chief Executive Officer

Funding Rounds

Funding rounds

7

Investors

1

Lead Investors

0

Total Funding Amount

$16.0M

Details

5

AmacaThera has raised a total of $16.0M in funding over 5 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2015Seed
2016Seed
2021Early Stage Venture10.3M
2023Early Stage Venture2.9M

Investors

AmacaThera is funded by 34 investors.

Investor NameLead InvestorFunding RoundPartners
AmacaThera-FUNDING ROUND - AmacaThera2.9M
Paul Austin-FUNDING ROUND - Paul Austin2.9M
AmacaThera-FUNDING ROUND - AmacaThera50.0K
Toronto Innovation Acceleration Partners-FUNDING ROUND - Toronto Innovation Acceleration Partners50.0K